IP Library Granted Patent US 12,359,161
Granted Patent B2
US 12,359,161 · App. 18/333,957 · Granted Jul 15, 2025

Microbiological growth media and methods of using the same

Inventors: Kate Shara (Nashua, NH); Julie Schwedock (Arlington, MA); Sommer Vogel (Lowell, MA)
Assignee: RAPID MICRO BIOSYSTEMS, INC.
C12N1/20C12N1/14C12N1/16C12N1/38C12Q1/045
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,359,161
App. No.
18/333,957
Granted
Jul 15, 2025
Kind
B2
Abstract

The present invention features general-purpose microbiological growth media capable of supporting growth of microorganisms on membranes. The media contain casein digest, soybean digest, animal tissue digest, yeast extract, dextrose, a phosphate buffer, hemin, and L-cystine. The invention features an all-purpose microbiological growth media that can support the growth of anaerobes, molds, injured spores, and general aerobic bacteria to a greater extent than other media.

Claims (21)

1. A method of preparing a composition, comprising: autoclaving a mixture comprising purified water, casein digest, soybean digest, a phosphate buffer, dextrose, animal tissue digest, yeast extract, hemin, and L-cystine; and adding sheep blood to the mixture, wherein the method does not comprises adding sodium to the mixture.

2. The method of claim 1 , further comprising cooling the mixture after autoclaving the mixture.

3. The method of claim 2 , wherein the mixture is cooled to room temperature.

4. The method of claim 1 , further comprising adjusting a pH of the mixture to 7.3±0.5 by adding at least one of sterile potassium hydroxide or hydrogen chloride to the mixture.

5. The method of claim 1 , further comprising holding a temperature of the mixture at about 65° C. until a color of the mixture changes from red to brown.

6. The method of claim 1 , wherein the mixture that is autoclaved further comprises a gelling agent.

7. The method of claim 1 , wherein the mixture that is autoclaved further comprises a surfactant.

8. The method of claim 1 , wherein the mixture that is autoclaved is free of added sodium.

9. The method of claim 1 , wherein, excluding the phosphate buffer from the total mass of the composition, the composition comprises between about 1 g/kg and about 500 g/kg of casein digest.

10. The method of claim 1 , wherein, excluding the phosphate buffer from the total mass of the composition, the composition comprises between about 0.5 g/kg and about 300 g/kg of soybean digest.

11. The method of claim 1 , wherein, excluding the phosphate buffer from the total mass of the composition, the composition comprises between about 1 g/kg and about 500 g/kg of animal tissue digest.

12. The method of claim 1 , wherein, excluding the phosphate buffer from the total mass of the composition, the composition comprises between about 1 g/kg and about 500 g/kg of yeast extract.

13. The method of claim 1 , wherein, excluding the phosphate buffer from the total mass of the composition, the composition comprises between about 1 g/kg and about 500 g/kg of dextrose.

14. The method of claim 1 , wherein the composition comprises a quantity of phosphate buffer sufficient to provide a buffer capacity of from 0.1 mmol/(pH unit) to 100 mmol/(pH unit) upon dissolution in an aqueous medium.

15. The method of claim 1 , wherein the mixture that is autoclaved does not comprise tris(hydroxymethyl) aminomethane.

16. The method of claim 1 , wherein the mixture that is autoclaved further comprises a disinfectant neutralizer.

17. The method of claim 16 , wherein said neutralizer is histidine, thiosulfate, polysorbate 80, and/or lecithin.

18. The method of claim 1 , further comprising contacting a population of cells with the composition under conditions supportive of growth of said population of cells.

19. A method of preparing a composition, comprising:

autoclaving a mixture comprising purified water, between about 1 g/kg and about 500 g/kg of casein digest, between about 0.5 g/kg and about 300 g/kg of soybean digest, a phosphate buffer, between about 1 g/kg and about 500 g/kg of dextrose, between about 1 g/kg and about 500 g/kg of animal tissue digest, between about 1 g/kg and about 500 g/kg of yeast extract, hemin, and between about 8 g/kg and about 40 g/kg of L-cystine, wherein said composition does not comprise tris(hydroxymethyl) aminomethane; and

adding sheep blood to the mixture.

Assignments (3)
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 8, 2025
From: RAPID MICRO BIOSYSTEMS, INC.
To: TRINITY CAPITAL INC.
Reel/Frame 072343/0134 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 8, 2025
From: RAPID MICRO BIOSYSTEMS, INC.
To: TRINITY CAPITAL INC.
Reel/Frame 072343/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 14, 2023
From: SHARA, KATE; SCHWEDOCK, JULIE; VOGEL, SOMMER
To: RAPID MICRO BIOSYSTEMS, INC.
Reel/Frame 063942/0256 →
Continuity (4)
Division 17063108 · Oct 5, 2020
Continuation 15305789
Provisional Application 61983675 · Apr 24, 2014
Related Publication 20230323283A1 · Oct 12, 2023
References Cited (7)
Thermo Fischer “Schaedler Blood Agar w/ and w/o Additives” IFU 1800, 2pgs, 2010 (Year: 2010). [cited by examiner]
Hameau “Schaedler Agar Base” Dehydrated Culture Medium, 2 pages, 2004 (Year: 2004). [cited by examiner]
European Pharmacopoeia 5th Ed. Main vol. 5.0, 2005 pp. 430-435 (Year: 2005). [cited by examiner]
Wichmann et al. “Isolation of Corynebacterium Group JK from Clinical Specimens with a Semiselective Medium” Journal of Clinical Microbiology, Feb. 1984, p. 204-206 (Year: 1984). [cited by examiner]
DSMZ “696. [cited by examiner]
Nghia et al. “Human Case of [cited by examiner]
UNC Compounding Lab “Buffers and Buffer Capacity” 2 pages 2009 (Year: 2009). [cited by examiner]